BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20498591)

  • 1. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer.
    Parashar B; Edwards A; Mehta R; Pasmantier M; Wernicke AG; Sabbas A; Kerestez RS; Nori D; Chao KS
    Am J Clin Oncol; 2011 Apr; 34(2):160-4. PubMed ID: 20498591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
    Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diabetes mellitus on the development of radiation pneumonitis in patients with non-small cell lung cancer].
    Song H; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):45-7. PubMed ID: 19538869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
    Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
    Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
    Zhang Y; Yu YH; Yu JM; He W; Fu Z; Guo SF; Liu XJ; Cong CS
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):622-5. PubMed ID: 20021952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].
    Ji W; Wang LH; Ou GF; Liang J; Feng QF; Xiao ZF; Chen DF; Lü JM; Zhou ZM; Zhang HX; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):783-6. PubMed ID: 19173815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.
    Kobayashi H; Uno T; Isobe K; Ueno N; Watanabe M; Harada R; Takiguchi Y; Tatsumi K; Ito H
    Jpn J Clin Oncol; 2010 May; 40(5):464-9. PubMed ID: 20085905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
    Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three-dimensional conformal radiotherapy for locoregionally recurrent non-small cell lung cancer after initial radiotherapy].
    Wang YJ; Wang LH; Lü JM; Zhao LJ; Xiao ZF; Zhang HX; Feng QF; Zhang Z; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):227-9. PubMed ID: 16875613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.